Catalyst Crew Technologies Corp. (OTC: CCTC) provided an update on its ongoing regulatory and deployment activities for its telehealth platform in Venezuela. The company is advancing early-stage testing and refinement of the platform, accessible at latamedai.org, where it is evaluating system performance and user workflows as part of its initial launch.
The platform is designed to support remote patient engagement, care coordination, and integration of artificial intelligence-driven healthcare analytics. Current efforts focus on enhancing functionality, improving data integration, and optimizing user experience. In parallel, the company is working with Venezuela's Ministerio del Poder Popular para la Salud and the Servicio Autónomo de Contraloría Sanitaria (SACS) to obtain the required Permiso Sanitario de Funcionamiento para Plataforma Digital. The regulatory process involves addressing documentation, operational procedures, and compliance standards.
Management anticipates that the permitting process may be completed in the near term, but no assurance can be provided on timing or outcome. The company believes this phase is an important step toward broader operational rollout across its target markets. Dr. Kevin Rodan Levy, CEO, stated that the focus is on building a scalable telehealth platform that can operate effectively in real-world healthcare environments, and that a full launch is expected upon receiving all regulatory approvals.
Catalyst Crew Technologies continues to advance its digital health and AI platform, including telehealth infrastructure and AI-driven healthcare analytics capabilities. For more information, visit catalystcrewai.com or review the company's SEC filings at www.sec.gov.
